Raymond James Financial, Inc. (NYSE: RJF) — The Advisor’s Firm, Re-Rated to Fair: Real Capital, a Rolling-Over Rate Windfall, and Nowhere Cheap Left

Independent equity research. As-of date: 2026-07-03. Fiscal year ends September 30.

⚡ Claude’s Take

This block is the author’s own independent opinion and general information only — it is not investment advice and not a recommendation to buy or sell any security. The analytical body that follows takes no position and carries no price target by design.

Verdict: HOLD / accumulate-on-weakness. A top-quartile wealth franchise, conservatively capitalized, now priced for the quality it has earned — a quality-compounder-at-a-fair-price, not a bargain. At $162.66 (2026-07-02) RJF trades ~15.4x trailing / ~14.5x forward earnings, ~2.4x book and ~3.1x tangible book, against a mid-teens ROE (16.7% FY25) and ~21% adjusted return on tangible common equity. That is a fair multiple for one of the best-run diversified wealth managers in the U.S. — but the two easy tailwinds that carried the stock from $48 (2020) to $176 (2025), a re-rating from 1.5x to 2.5x book and a once-in-a-decade net-interest-income windfall, are both behind it. I’d be a patient accumulator, not a chaser, especially after a +9% two-day pop (Jul 1–2) that was a sector rate-rally, not a company event.

Framing: quality compounder at a fair-to-full price — the opposite of a falling knife. The factor tape confirms it: beta ~0.94, a pronounced low-volatility / dividend / quality loading, an 18%-annualized 10-year track record with a 0.52 Sharpe, and a quiet trailing year (+4.2%). This is a steady-eddie name that rarely gets cheap. My accumulation zone is sub ~$140–145 (≈13x normalized EPS, ~2.0x book — roughly the April-2025 tariff-scare low); my fair-value zone is ~$150–185 (≈14–16x a normalized ~$11.0–11.5 EPS). Conviction: medium. The single fact that flips me bullish: management deploys the ~$2.1B of excess capital into a large, culturally-clean wealth acquisition and the capital-markets cycle inflects — a genuine earnings step-up. The single fact that flips me bearish: net-new-asset growth keeps decelerating (7.7%→5.5%→3.8% FY23→FY25) while rate cuts hollow out NII and the advisor-comp war grinds PCG margins — quality slipping toward the industry average at an above-average multiple.

Tag: “The best-capitalized house on the street, finally priced like it.”

📈 Stock Price Action — Five-Year Event Map

RJF has round-tripped from a COVID-era ~$48 (Oct-2020) through a five-year, roughly 3.5x advance to an all-time high of $176.43 (29 Sep 2025), and sits today at $162.66 (2 Jul 2026) — about 8% off the high, inside a 52-week range of roughly $138.82–$177.66. The arc is two stories stacked: a re-rating (1.5x → ~2.5x book as the market accepted RJF as a durable high-teens-ROE compounder rather than a cyclical broker) layered on a rate windfall (2022–24 Fed hikes turned client cash sweep into a high-margin NII engine). Both drivers have now matured. The price is a FACT; the attributed cause is INTERPRETATION.

Cycle narrative. (1) RJF de-rated hard in 2022 with the whole financial complex as recession and rate-shock fear compressed multiples. (2) Then the very rate shock that hurt the multiple made the earnings: rising short rates turned ~$50–60B of essentially free client sweep cash into a high-spread NII machine, and the stock recovered as record earnings power was recognized. (3) The March-2023 regional-bank crisis briefly re-priced every broker-bank for deposit flight — RJF hit its five-year low near $83 — but its conservative funding and capital proved the fear overdone. (4)–(5) The 2024–25 leg was the payoff: durable NII, record fee-based assets, industry-leading net-new-asset growth and steady buybacks drove a ~60% advance and a full re-rating to ~2.5x book / an all-time high. (6) A tariff-shock drawdown in spring 2025 took the stock down ~28% to ~$125 — the most recent point at which RJF was genuinely cheap. (7) It has since recovered, and the final leg to $163 includes a July-1–2 2026 sector pop (a dovish Fed-chair signal lifting the entire banking/financials tape, per Benzinga) that is macro, not RJF-specific — and, ironically, dovish rates are a mild headwind to RJF’s NII.

1. Executive Summary

Raymond James Financial is a St. Petersburg, Florida–headquartered diversified financial-services firm built around one dominant engine — the Private Client Group (PCG), a ~$1.67 trillion advisor-driven wealth platform — supported by three complementary segments: Capital Markets (investment banking, fixed-income and equity brokerage), Asset Management, and a Bank (Raymond James Bank plus TriState Capital). PCG generates roughly 65–70% of net revenue and is the source of the firm’s identity: RJF competes for financial advisors on an “AdvisorChoice” multi-affiliation model (employee, independent contractor, RIA, custody) and has become, by broad industry agreement, the most effective recruiter of breakaway and displaced advisors in the country — it won roughly one-in-three departing Commonwealth advisors during LPL’s 2025–26 integration and reached record headcount of 8,943 advisors.

The business is genuinely high-quality. Over FY20–FY25 net revenue compounded from $7.9B to $13.8B (~12%/yr), diluted EPS from $3.89 to $10.30 (~21%/yr), and return on equity settled into a durable high-teens band (16.7% FY25, 18.7% FY24) with adjusted return on tangible common equity around 21%. The firm is conservatively capitalized to a fault — a 13.1% consolidated Tier-1 leverage ratio, a 24.1% total-capital ratio, positive tangible book value of ~$52/share, net cash at the parent, and roughly $2.1B of excess capital above its own conservative 10% leverage target. It returns capital steadily (buybacks plus a low ~19%-payout dividend; ~94% of trailing earnings returned) and grows book value ~13–15%/yr.

The investment tension is not about quality — it is about price and the direction of two tailwinds. RJF’s five-year total return was powered by (i) a multiple re-rating from ~1.5x book to ~2.5x book and (ii) a net-interest-income windfall as 2022–24 rate hikes monetized ~$50–60B of client cash sweep. Both have now matured: the multiple sits near the top of its five-year range, and the Fed is easing — cash-sweep balances have already bled to just 3.7% of PCG assets (~$57.8B) as clients moved to higher-yielding alternatives, and NII/RJBDP fees are flat-to-declining. Meanwhile the headline organic-growth metric — domestic PCG net new assets — has decelerated from 7.7% (FY23) to 3.8% (FY25), even as recruiting stays strong. The offsets are real: fee-based AUM growth (fee-based AUA $1.01T, +20% YoY), securities-based-lending growth (+31% YoY), an inflecting capital-markets/IB pipeline, and a fortress balance sheet with ample M&A firepower.

At ~15.4x trailing / ~14.5x forward earnings and ~2.4x book, RJF is priced roughly in the middle of its peer cohort — cheaper than Schwab (~16.9x, 3.2x book), Morgan Stanley (~18x) and LPL, richer than Ameriprise (~11.6x) and Stifel (~13.5x) — and, distinctively, is the only wealth pure-play in the group carrying a meaningful positive tangible book (real, un-levered capital rather than buyback-hollowed equity). The embedded expectation is continued ~8–12% EPS growth with mid-teens ROE — achievable, but not conservative. This is a business worth owning at the right price; the current price already pays for the quality. No recommendation or price target appears below; see Claude’s Take above for the one fenced-off view.

2. Business Overview

Raymond James Financial (founded 1962; NYSE: RJF; FY-end September 30) is a diversified financial-services holding company operating through four reportable segments plus an “Other” bucket. The through-line of the whole enterprise is financial advice delivered by human advisors, with every other business either feeding or monetizing that advisor-client relationship.

Private Client Group (PCG) — the core (~65–70% of net revenue). PCG is a wealth-management platform serving ~$1.67 trillion of client assets under administration (AUA) as of September 30, 2025, of which $1.01 trillion is fee-based (the recurring, asset-based-fee portion that is the highest-quality revenue in the firm). PCG is delivered through 8,943 financial advisors affiliated under the firm’s “AdvisorChoice” model — a deliberately broad set of affiliation options: traditional employee advisors (Raymond James & Associates), independent contractors (Raymond James Financial Services), independent RIAs, and financial-institution/bank-based advisors. RJF makes money in PCG three ways: (i) asset-management and administrative fees on fee-based accounts (the largest and most recurring line — $2.02B firm-wide in Q2-26, +17% YoY); (ii) transactional commissions on brokerage; and (iii) net interest / spread on client cash and margin. The advisor is paid via a payout grid (higher for independents, who absorb their own overhead), which is why PCG’s compensation ratio is high and rises as recruiting mix shifts toward independents.

Capital Markets (~10–12% of net revenue). Investment banking (equity and debt underwriting, M&A advisory), institutional fixed-income and equity brokerage, and public-finance/municipal underwriting. This is RJF’s most cyclical segment: Q2-26 net revenue was $464M with pretax income of just $51M (an ~11% pretax margin), depressed relative to its potential because the IB cycle has been muted. Management describes a “robust” and improving pipeline (March 2026 was unusually strong), largely sponsor-driven, and has been investing in the platform (the GreensLedge acquisition, a debt-capital-markets/CLO boutique, closed in Q2-26).

Asset Management (~8% of net revenue, high-margin). Raymond James Investment Management and the Asset Management Services (AMS) division provide managed/fee-based programs to PCG clients and third-party institutions. Q2-26 net revenue $327M with pretax income of $137M — a ~42% pretax margin, the firm’s most profitable segment on a margin basis. Financial assets under management benefit both from market appreciation and from PCG net inflows into fee-based accounts. The pending Clark Capital acquisition adds managed-account capability.

Bank (~12–13% of net revenue). Raymond James Bank and TriState Capital Bank (acquired 2022) hold record loans of $54.8B (Q2-26, +14% YoY). The loan book is deliberately low-risk and synergistic with wealth: securities-based loans (SBL) are ~42% of loans and grew ~31% YoY, residential mortgages ~20%; together ~62% of the book. The bank is funded primarily by the Raymond James Bank Deposit Program (RJBDP) — client cash swept from PCG accounts — plus TriState’s deposit franchise. Net interest margin was 2.81% in Q2-26.

Other / corporate. Private-equity investments, corporate interest, and unallocated items.

Geographically, RJF is ~91% U.S., ~5% Canada, ~4% Europe (the small European operation runs at a modest pretax loss). Revenue quality is high and recurring: the dominant lines are asset-based fees (recurring, growing with markets and net flows) and net interest (recurring but rate-sensitive); transactional and investment-banking revenues are the cyclical minority. Verdict: a well-diversified, advice-centric wealth franchise where the cyclical capital-markets tail does not wag the recurring wealth-and-bank dog — a structurally attractive revenue mix.

3. Industry Dynamics

RJF competes in U.S. wealth management and brokerage, a large, growing, and structurally attractive profit pool — but one whose economics are being actively contested along two axes: the price of advisor talent, and the durability of cash-sweep spread income.

Market size and growth. U.S. retail wealth is a multi-tens-of-trillions asset base compounding with market appreciation, demographic wealth transfer, and the secular shift from commission/transactional to fee-based advice. Fee-based (advisory) assets have been taking share from brokerage for two decades; RJF’s own fee-based AUA (+20% YoY to $1.01T) illustrates the mix shift. The advisor headcount pie is roughly flat-to-shrinking industry-wide (advisors are aging — an estimated ~40% of the workforce is near retirement across the industry), which turns wealth management into a share-of-a-fixed-talent-pool contest and elevates the value of recruiting, retention, and succession programs.

Competitive structure. The industry is an oligopoly of scaled platforms differentiated by channel: wirehouses (Morgan Stanley, Merrill, UBS, Wells Fargo Advisors) at the up-market/employee end; independent broker-dealers and custodians (LPL Financial, Raymond James, Ameriprise, Commonwealth [now LPL], Cetera, Osaic) in the middle; discount/self-directed custodians (Schwab, Fidelity) at the RIA/self-directed end. RJF sits in the sweet spot — branded, advice-led, multi-affiliation — positioned to catch advisors leaving both the constrained wirehouse culture and the thinly-supported independents.

The advisor-recruiting war (the dominant competitive dynamic). Because the end client largely follows the advisor, not the platform, the scarce asset is the advisor — and platforms compete for them with escalating transition assistance (TA) (upfront recruiting loans, now at cycle-high richness) and payout. This is a genuine margin governor: no platform has durable pricing power over a mobile advisor. RJF’s edge here is qualitative and, per management, cultural — it recruits “one-by-one” for cultural fit rather than doing hostile roll-ups, and now discloses its recruiting/retention spend separately (annual recruiting is “a medium-sized acquisition”). The evidence that its value proposition is winning: RJF captured ~1-in-3 departing Commonwealth advisors and posted its second-highest-ever quarterly recruited production/assets in Q2-26.

Cash-sweep / NII sensitivity (the dominant financial dynamic). For every broker-bank, a large slice of profit is spread on client cash. RJF earns NII on bank loans funded by swept deposits, plus RJBDP fees on cash placed at third-party banks. This income exploded when the Fed hiked in 2022–24, and is now under two pressures: (i) rate direction (the Fed is easing; yields on RJBDP third-party balances fell 6bps in Q2-26 to 2.7%), and (ii) cash-sorting (clients move idle cash to higher-yielding money-market and enhanced-savings alternatives — industry sweep balances have fallen 40–50% from peak; RJF sweep is down to 3.7% of PCG assets, ~$10k/account average). The emerging bear overlay is “agentic AI cash optimization” — the fear that software will further hunt down idle sweep cash. Management’s rebuttal (Q2-26 call) is credible: the cash-sorting has already largely happened without AI, sweep balances have stabilized for several quarters, and an advisor-intermediated platform (unlike an e-broker) has less idle cash left to lose.

Regulation. Broker-dealers and the bank subsidiaries are heavily regulated (SEC/FINRA; the bank by the Fed/OCC/FDIC). Reg BI, fiduciary standards, and periodic SEC scrutiny of cash-sweep practices are live items (an SEC industry cash-sweep probe was a 2025 overhang, largely resolved without action for peers). Capital requirements bind the bank subsidiaries, but RJF runs so far above minimums that regulation is a governor on aggressiveness, not on viability. Verdict: structurally attractive industry — growing fee pool, high switching costs at the advisor level, oligopolistic structure — but with two genuine margin/earnings governors (advisor TA inflation and cash-sweep/rate sensitivity) that cap how good the economics can get and that are currently trending against the group.

4. Competitive Position

Does RJF have a moat? Yes — a real but bounded one, of the “customer captivity + local economies of scale in advisor support” type (Greenwald taxonomy), plus a genuine brand/culture intangible. The mechanism is worth stating precisely because the moat lives at the advisor layer, not the end-client layer.

1. Advisor switching costs and captivity (the core moat). Once an advisor affiliates with RJF and moves a $150M+ book onto its platform, the friction of moving again is high: repapering client accounts, re-earning client consent, forfeiting unvested transition assistance, and disrupting client relationships. RJF’s retention is consistently strong (management cites it as the larger driver of net-new-assets than recruiting), and its recruited-advisor productivity is high. The financial fingerprint of this captivity: industry-leading net-new-asset generation — management claims ~7% annualized organic NNA in H1-FY26, “leading the industry,” versus Schwab ~5% and a decelerating LPL. If this moat did not exist, NNA would not persistently outrun a shrinking advisor pool and retention would leak; it does not.

2. Local/relationship economies of scale in advisor support. RJF spends $1.1B+ annually on technology, almost all of it focused on wealth-management tooling for advisors (unlike a Schwab or a bank that must spread spend across payments, cards, treasury). That concentration lets a mid-sized platform deliver advisor-facing technology that “blows away” what advisors see even at the largest wirehouses (management’s claim, corroborated by RJF’s consistent industry technology awards and recruiting win-rate). This is a scale advantage within the wealth niche — RJF need not out-spend JPMorgan in aggregate, only out-focus it per-advisor.

3. Brand and culture as an intangible. RJF’s differentiation is repeatedly framed — by management, by competitors’ analysts, and by advisor surveys — as “you don’t have to choose between culture and capabilities.” The “invite firms into the family and keep them intact” acquisition philosophy (Morgan Keegan 2012, TriState 2022, and fixed-income leadership still run by legacy Morgan Keegan people) is a genuine, hard-to-replicate cultural asset that lowers integration/attrition risk and makes RJF a preferred merger partner. Culture is normally an un-bankable soft factor; here it converts to a measurable recruiting win-rate and retention, so it clears the “moat must show up in financials” test.

Direct competitor read. Versus LPL Financial: LPL is larger (~$1.9T) and lower-cost/more-scaled at the infrastructure layer, but its advisors are more purely “rented” (thin culture, higher payout) — and RJF is the single most effective poacher of LPL/Commonwealth breakaways, which is prima facie evidence LPL’s retention is not a fortress. Versus Ameriprise (the closest analog — branded, advice-led, bank/NII leg + a capital-markets/asset-management complex): AMP runs higher advisor productivity and a far higher (partly artificial, thin-equity) ROE, but RJF carries a more conservative balance sheet and a capital-markets franchise. Versus Morgan Stanley / wirehouses: RJF wins the culture/independence dimension; the wirehouses win scale and up-market/UHNW. Versus Schwab/Fidelity: different model (custody/self-directed vs. full-service advice); RJF is not trying to win the price-sensitive self-directed client.

The moat’s boundaries (be direct). The moat is bounded by the advisor’s mobility and by the recruiting-cost war. RJF cannot raise its “price” to advisors (i.e., cut payout) without losing them; it must keep spending on TA and technology to hold share. And the moat does not extend to the cash-sweep economics, which are a rate-cycle windfall, not a durable advantage. Verdict: a durable but bounded moat — genuine advisor captivity, focused scale in advisor support, and a rare culture intangible that shows up in industry-leading retention and recruiting — offset by a structural inability to price the advisor and by earnings leverage to a mean-reverting rate spread.

5. Growth History and Forward Opportunities

History (high-quality, mostly organic). RJF’s five-year record is strong and, importantly, largely organic:

Net revenue compounded ~12%/yr and diluted EPS ~21%/yr (the EPS growth exceeding revenue reflects operating leverage, the NII windfall, tax, and a ~8% reduction in share count). Book value per share more than doubled. The growth came from three reinforcing sources: market appreciation on asset-based fees, net new assets (recruiting + retention), and the NII step-up. The one acquisition of scale in the window — TriState Capital (2022) — added the SBL engine and a diversified deposit base and has been a clear success (SBL up ~31% YoY, deposit growth >50% since acquisition).

The deceleration flag. The single most important trend to watch is domestic PCG net-new-asset growth, which has decelerated three years running: 7.7% (FY23) → 5.5% (FY24) → 3.8% (FY25) on absolute NNA of $73.3B → $60.7B → $52.4B. Management points to a H1-FY26 rebound (~7% annualized) and record recruiting pipelines, and some of the FY24–25 slowdown reflects a denominator that grew with markets — but a persistent NNA slowdown at an above-average multiple is the bear’s best evidence.

Forward opportunities. (1) Advisor recruiting share — a genuinely open runway while wirehouse and private-equity-backed competitors face their own catalysts (management noted private-equity aggregators struggling to raise capital, a potential source of both recruits and eventual acquisition targets). (2) Securities-based lending — ~31% YoY growth with “significant” runway to deepen penetration of PCG’s own $1.67T asset base; a high-return, low-credit-risk way to deploy the balance sheet. (3) Fee-based mix shift — continued migration from brokerage to advisory lifts recurring revenue. (4) Capital-markets recovery — an IB cycle inflection is pure upside optionality (the segment is under-earning). (5) M&A — ~$2.1B of excess capital and a proven “keep-it-intact” integration model position RJF for a large, accretive wealth or asset-management acquisition if a culturally-compatible target becomes available. Verdict: high-quality growth — organic, fee-based, capital-light at the margin (SBL and fee-based assets), and reinvested at high incremental returns — but decelerating on the headline NNA metric, so the quality is better than the current trajectory of the single most-watched growth KPI.

6. Financial Quality

Earnings quality is high — but you must read it like a broker-bank, not an industrial. Two methodological points govern the analysis: (i) use net income and ROE/ROTCE, not operating cash flow, because RJF’s GAAP operating cash flow swings violently with client-balance and brokerage-payable flows (−$3.5B in FY23, +$72M FY22, +$2.4B FY25) — those swings are client money moving, not earnings quality; and (ii) EV/EBITDA is meaningless here (aggregator “EBITDA” of ~$195M is merely D&A; aggregator EV nets operational client cash and is not a real capital structure). The right lenses are P/E, P/B, P/TBV, ROE/ROTCE, and capital ratios.

Margins and returns. FY25 pretax margin was ~19.6% (adjusted ~20%), consistent with the firm’s “~20% through-cycle” self-description, and notably achieved with capital markets under-earning. Return on common equity was 16.7% (FY25), down from 18.7% (FY24) as the equity base grew and NII normalized; adjusted return on tangible common equity ~21% (Q2-26). These are strong, durable returns for a diversified financial and comfortably above the firm’s cost of equity. Segment profitability in Q2-26 shows the mix: PCG pretax $416M (the volume engine), Asset Management ~42% pretax margin (the highest-margin business), Bank pretax $166M (spread), Capital Markets $51M (the cyclical laggard with upside).

Revenue composition. ~55–60% of net revenue is recurring asset-based and administrative fees; a further ~12–15% is net interest (recurring but rate-sensitive); the transactional/IB balance is the cyclical minority. This is a better revenue-quality mix than a pure investment bank or a pure transactional broker.

Balance sheet — a genuine fortress. Total assets $88.2B against $12.5B of equity (FY25). The tangible common equity ratio is 12.2%, the consolidated Tier-1 leverage ratio 13.1%, and the total-capital ratio 24.1% — RJF runs roughly double the regulatory minimums and above its own conservative internal 10% leverage target, leaving ~$2.1B of excess capital. The parent held ~$3.0B corporate cash (Q2-26), ~$1.8B above its $1.2B liquidity target. Net debt is negative (net cash). The loan book is low-risk (SBL + resi mortgage = 62%), credit quality “strong,” and reserves adequate. This conservatism is the single most under-appreciated fact about RJF: unlike LPL and Ameriprise, whose high ROEs partly reflect buyback-hollowed, thin, or negative tangible equity, RJF earns its high-teens ROE on a fully-capitalized, positive-tangible-book balance sheet — the return is real, not financially engineered.

Dilution / SBC. Stock-based compensation is modest (~$254M FY25, ~12% of net income), and RJF is a net repurchaser — diluted share count fell from 215M (FY22) to ~206M and outstanding shares to 198M. Unit economics improve with scale: incremental fee-based assets and SBL carry high incremental margins, and technology spend, while large in absolute terms ($1.1B+), is a share-gaining investment rather than a treadmill cost. Verdict: yes — economics improve with scale, earnings are high-quality and well-capitalized, and the only asterisks (violent GAAP OCF swings, rate-sensitive NII) are understood features of the model, not red flags.

7. Capital Allocation

Verdict up front: RJF’s capital allocation is disciplined, shareholder-friendly, and conservative — among the best in the peer group — with the only mild critique being that its very conservatism leaves a large excess-capital “lazy balance sheet” that management has been slow to deploy into a needle-moving acquisition.

Organic reinvestment first. Management’s stated and revealed priority is organic growth: recruiting/retention TA (explicitly reframed as “a medium-sized acquisition” of spend each year, and now separately disclosed for transparency), the $1.1B+ annual technology investment, and balance-sheet deployment into high-return SBL. These are high-incremental-return uses and the right first call on capital.

M&A — patient and culturally disciplined. RJF is not a serial acquirer; it does selective, culture-first deals it can integrate without destroying the target: Morgan Keegan (2012, fixed income), Charles Stanley (UK), NWPS/retirement, TriState Capital (2022, SBL + deposits — a clear win), GreensLedge (2026, debt capital markets, closed Q2-26), and Clark Capital (2026, managed accounts, closing). The discipline is real — management explicitly declines “takeovers,” prefers one-by-one recruiting to acquisitions because 100% of TA then goes to retention, and waits for culturally-compatible partners rather than overpaying. The cost of this discipline is that ~$2.1B of excess capital sits under-deployed; the benefit is no history of value-destructive empire-building.

Shareholder returns — steady and growing. Over the trailing twelve months (through Q2-26) RJF returned >$2B to shareholders (~94% of earnings): ~$1.6B of buybacks plus dividends. The dividend is deliberately modest (payout ratio ~19%; yield ~1.3%) — RJF prioritizes retaining capital to fund organic growth and buybacks over a high payout, which is the correct choice for a ~13–15% book-value compounder. Buybacks have been executed at sensible prices (Q2-26 repurchases at ~$155 average, below the current $163) and have shrunk the share count ~8% over five years. The firm also opportunistically redeemed its Series B preferred ($81M) in January 2026, simplifying the capital structure.

Incentive alignment. Executive compensation is anchored to relative total shareholder return (rTSR) versus a defined peer group over three years, plus performance RSUs — a genuinely shareholder-aligned structure. Governance is owner-oriented: founder’s son Thomas A. James (Chairman Emeritus, director since 1970) and the James family retain a meaningful long-term stake, and the 2025 CEO transition (Paul Reilly → Paul Shoukry, a 16-year insider) was an orderly internal succession that preserved the culture. The one governance nuance to note honestly is that concentrated founder-family influence and a clubby, long-tenured board can cut both ways — here it has reinforced the long-termism that defines the firm. Verdict: management has allocated capital intelligently — reinvesting at high returns, buying back stock sensibly, keeping the balance sheet conservative, and avoiding value-destruction — with the only quibble being an arguably too-large capital cushion awaiting deployment.

8. Changes and Headwinds — Last Two Years

Strategic / corporate changes. (1) CEO succession — Paul Shoukry succeeded long-serving Paul Reilly as CEO in 2025, an orderly internal handoff; Butch (Jonathan) Oorlog is CFO. (2) Acquisitions — GreensLedge (debt capital markets/CLO, closed Q2-26) and Clark Capital (managed accounts, closing) extend Capital Markets and Asset Management; both are bolt-ons, not transformational. (3) Series B preferred redemption (Jan-2026, $81M). (4) Continued SBL and deposit build at TriState. (5) An Investor Day was held in mid-2026 (referenced on the Q2 call) laying out longer-term margin/growth targets.

Operating tailwinds (last two years). Record fee-based AUA ($1.01T, +20% YoY); record bank loans ($54.8B); industry-leading advisor recruiting (second-highest quarterly recruited production ever in Q2-26; ~1-in-3 Commonwealth breakaways); an improving IB pipeline (strong March 2026).

Headwinds (be direct). (1) Rate direction has turned against NII — the Fed is easing; RJBDP third-party yields are falling (−6bps in Q2-26) and combined NII + third-party fees are flat-to-down (~$650M, −3% QoQ). The 2022–24 windfall is now a modest drag. (2) Cash-sorting has structurally shrunk the highest-margin (sweep) cash to 3.7% of PCG assets; while it has stabilized, it is unlikely to rebuild materially at lower rates. (3) NNA deceleration (7.7%→3.8% FY23→FY25) despite strong recruiting. (4) PCG margin pressure — the compensation ratio has ground up (65.8% in Q2-26) even as revenue grows, driven by a mix shift toward higher-payout independent advisors and rising recruiting/retention spend; operating leverage in PCG has been negative in recent quarters. (5) Capital-markets softness — IB has been under-earning through a muted cycle. (6) The “agentic AI cash-optimization” narrative — a market overhang ascribing a lower terminal value to cash-derived profits across the sector (it has pressured RJF and peer stocks on specific AI-product headlines). (7) Macro/market beta — asset-based fees fall with markets, as the ~28% tariff-shock drawdown in spring 2025 demonstrated. Verdict: the recent changes are net neutral-to-mildly-negative for the thesis — the franchise is strengthening (recruiting, SBL, fee-based mix, IB optionality) but the two profit tailwinds that supercharged FY22–24 earnings (rates and re-rating) have both reversed or matured, which is precisely why quality alone does not make the stock cheap here.

9. Risk Analysis (Risk Matrix)

Summary. RJF has no single existential risk. Its risk profile is dominated by earnings-sensitivity risks (rates/NII, cash-sorting, market beta, NNA/margin) rather than solvency or fraud risks. The balance sheet all but eliminates catastrophic-loss risk; the real question is whether earnings growth slows as the rate windfall reverses — a valuation risk, not a survival risk.

10. Valuation Discussion (Embedded Expectations)

No price target and no recommendation. This section frames what the market is underwriting.

Where the multiple sits. At $162.66 (2026-07-02), on ~198M shares (~$32B market cap; ~$33.5B diluted), RJF trades at:

• ~15.4x trailing GAAP diluted EPS (TTM ~$10.57) and ~14.5x forward (a normalized ~$11.0–11.5 FY26 estimate; H1-FY26 adjusted EPS run-rate ~$2.83/qtr);
• ~2.4x book ($67.4 FY25 BVPS, growing) and ~3.1x tangible book ($52.4);
• a ~1.3% dividend yield with a ~19% payout, and a total shareholder-return yield of ~6% (dividend + ~$1.6B buyback on ~$32B cap).

Against its own five-year history, the picture is “modestly full, not extreme”: AZI own-history percentiles put trailing P/E at the 54th percentile (mid-range) but P/S at the 81st (rich, because margins expanded) and the composite at the 68th. The stock has re-rated from ~1.5x book (FY20) to ~2.4–2.6x — that re-rating is done. P/B of ~2.4x is near the high end of the FY20–25 range (1.54x → 2.56x), though off the FY25-peak 2.56x.

Peer comparison (the cohort spine).

RJF sits mid-pack: cheaper than SCHW/MS/GS/LPL(adj)-ex-AMP on earnings, richer than AMP and Stifel. The distinctive fact is the P/B and tangible book: RJF’s ~2.4x book is the lowest of the wealth pure-plays that has real positive tangible equity behind it — LPL (4.2x) and AMP have negative or thin tangible book, so their lower headline P/E is partly a thin-equity artifact. On a quality-adjusted basis (fully-capitalized, positive-TBV, conservative), RJF’s ~15x is arguably the most honest multiple in the group.

Scenario framing (illustrative, not a forecast).

• Bear (~$120–135): rate cuts and cash-sorting keep NII flat-to-down; NNA deceleration continues; PCG margin grinds; capital markets stay muted → EPS stalls near ~$10.5–11 and the multiple de-rates toward ~11–12x / ~1.8–2.0x book. This is roughly the spring-2025 tariff-scare low.
• Base (~$150–185): organic growth ~mid-single-digit, fee-based mix and SBL offset NII roll-off, buybacks continue, IB modestly recovers → EPS ~$11.5–12.5 over the next 1–2 years at ~14–16x → the current zone.
• Bull (~$200+): capital-markets cycle inflects meaningfully and the $2.1B excess capital funds a large accretive wealth acquisition, driving an earnings step-up to ~$13–14 with the multiple holding ~15–16x.

Embedded expectation. At ~14.5x forward, the market is underwriting continued high-single-to-low-double-digit EPS growth with a durable mid-teens ROE — i.e., it expects RJF to keep out-growing its shrinking-advisor-pool industry on fee-based assets and buybacks while NII merely holds. That is achievable but not conservative: it gives little credit for a NII rebound (correctly, given easing) and requires the recruiting/retention machine to keep offsetting cash-sweep and margin headwinds. The market is pricing the quality correctly and the growth optimistically; there is no large obvious mispricing in either direction at $163.

11. Variant Perception

Consensus view. RJF is a high-quality, well-run, conservatively-capitalized diversified wealth manager that deserves a premium to pure brokers and trades at a fair mid-teens multiple; a “sleep-well-at-night” financial with steady compounding, industry-leading recruiting, and a fortress balance sheet. This consensus is, in our view, substantially correct — which is itself the problem for generating alpha.

Strongest bull case. RJF is a structural share-gainer in a consolidating industry whose earnings are under-stated by a depressed capital-markets cycle and a fortress balance sheet carrying $2.1B of un-deployed capital. As the IB cycle turns and management finally deploys excess capital into a culturally-clean acquisition, earnings step up while the fee-based/SBL engines compound at high incremental returns — and the market pays up for the only wealth pure-play with real tangible capital behind its high-teens ROE. The recruiting flywheel (best-in-class culture + $1.1B tech spend) keeps winning breakaways as private-equity aggregators falter.

Strongest bear case. RJF’s FY22–24 earnings power was flattered by a rate windfall that is now reversing, and the stock’s five-year re-rating from 1.5x to 2.5x book has already priced the quality. Underneath, the core organic-growth KPI (NNA) is decelerating (7.7%→3.8%), PCG operating leverage has turned negative (comp ratio grinding up as recruiting costs and independent-mix rise), cash-sweep — the highest-margin dollar — is structurally shrinking, and “agentic AI” threatens the terminal value of cash economics sector-wide. Buy a mid-teens multiple on peaking-quality earnings and you get a business converging toward the industry average at an above-average price.

The 3–5 assumptions that matter most:

1. NII / cash-sweep durability — does fee-based and SBL growth fully offset the NII roll-off as rates fall? (Q2-26: it nearly did.)
2. NNA trajectory — is the FY23→25 deceleration a market-denominator artifact that the H1-26 rebound refutes, or a genuine slowdown?
3. PCG margin — does the comp ratio stabilize, or does the advisor-TA war keep grinding operating leverage negative?
4. Capital deployment — does the $2.1B excess capital become an accretive acquisition (bull) or sit lazy / fund a mispriced deal (bear)?
5. Multiple — does ~2.4x book hold as the rate windfall fades, or de-rate toward the historical ~2.0x?

Falsification evidence. The bull is falsified if NNA growth stays below ~4–5% for another two years while the comp ratio keeps rising and NII declines — quality is then demonstrably fading at a premium multiple. The bear is falsified if RJF sustains ~6%+ organic NNA, holds PCG margin, and grows EPS double-digits without a NII tailwind — proving the franchise, not the rate cycle, drives the earnings.

Factor-positioning read (from the momentum/factor overlay). RJF is not a crowded momentum trade nor an abandoned value name — it is a low-volatility / dividend / quality name (beta ~0.94; strong DividendYield and Market loadings; a modest quality tilt) with an 18%-annualized 10-year track record (0.52 Sharpe) but a quiet trailing year (+4.2%). The tape says “steady compounder that rarely gets cheap,” which corroborates the fundamental read: the variant-perception opportunity is not a mispricing to exploit today but a price to wait for — the stock’s own low-vol character means the accumulation windows (2020 COVID, May-2023 SVB, Apr-2025 tariffs) are drawdown-driven and infrequent. Consensus is not obviously offsides; patience, not contrarianism, is the edge here.

12. Fact vs. Interpretation Table

13. Open Questions

1. NNA quality of the H1-26 rebound — is the ~7% annualized figure recruiting-front-loaded (one-time TA-driven) or a durable re-acceleration of organic client flows?
2. Terminal cash-sweep economics — where does sweep stabilize as a % of PCG assets in a lower-rate world, and what is the true steady-state NII contribution?
3. PCG margin floor — does the comp ratio stabilize near ~66%, or is the independent-mix shift structural and ongoing?
4. Excess-capital use — what is the realistic timeline and target profile for a large acquisition, and would management ever return the cushion via a special dividend / accelerated buyback instead?
5. Investor-Day targets — what through-cycle margin, ROE, and organic-growth targets did management set, and how do they bracket the NII normalization?
6. Capital-markets normalized earnings power — what does CapMkts pretax look like mid-cycle vs. the current ~$50M/quarter trough?
7. Insider activity — are there any recent open-market purchases (vs. routine grants/sales) by the James family or new-CEO Shoukry that would signal conviction at current prices? (Not established in this review.)

14. What Must Be True

For the bull case (own it here and it compounds):

• Organic NNA re-accelerates and holds ≥ ~6%, proving the franchise (not the rate cycle) drives growth; recruiting/retention keeps winning share in a shrinking-advisor industry.
• Fee-based + SBL growth fully offsets NII roll-off, so EPS grows double-digits without a rate tailwind.
• Excess capital is deployed accretively (a culturally-clean acquisition or disciplined buyback), and capital markets inflect — an earnings step-up the market rewards with a held/expanded multiple.
• Falsification test: if, over the next 8 quarters, NNA growth averages < ~4.5% and the PCG comp ratio rises further and EPS growth slips to low-single-digits, the bull thesis is broken — RJF is then a quality-fading business at a premium price.

For the bear case (avoid / expect de-rating):

• Rate cuts + cash-sorting drive NII structurally lower with fee growth failing to fully offset, capping EPS near ~$10.5–11.
• NNA deceleration persists and PCG operating leverage stays negative (comp ratio grinding up), signaling the recruiting war is eroding the moat’s economics.
• The multiple de-rates toward ~2.0x book / ~12x as the rate windfall and re-rating both fully unwind.
• Falsification test: if RJF sustains ~6%+ organic NNA, stabilizes PCG margin, and compounds EPS at double-digits through a full rate-cut cycle, the bear thesis is broken — the franchise is proven to be the driver and the premium is earned.

The synthesis: both cases hinge on the same three observables — NNA trajectory, PCG margin/comp ratio, and NII-vs-fee offset. That is exactly why the honest position is HOLD with a patience bias: the business is excellent and the balance sheet is a fortress, but at ~15x/2.4x book after a rate-driven pop, the market is paying for the quality and giving the growth the benefit of the doubt. The edge is price discipline — accumulate on the infrequent drawdowns this low-vol name provides — not a call that consensus is wrong.

15. Source Appendix

See the Source Appendix below for the full, dated source list. Primary sources: RJF FY2025 Form 10-K (filed 2025-11-25, for the year ended 2025-09-30); RJF fiscal Q2-2026 earnings call transcript (2026-04-22); RJF DEF 14A proxy statements; the trailing five-year SEC EDGAR corpus (10-K/10-Q/8-K/Form 4/DEF 14A). Quantitative cross-checks: third-party aggregated financials, ratios, enterprise value and per-share data; valuation-percentile and factor-model data; five-year price history. Peer/industry cross-reads: the public filings and disclosures of LPL Financial, Ameriprise, Charles Schwab, Morgan Stanley, Stifel, and StoneX. Every non-obvious fact is dated and attributed in the appendix.

APPENDIX A — Standard Diligence Questionnaire

Supplemental to the research memo. As-of 2026-07-03. Fact/Interpretation/Assumption labeled where it matters.

General

What thoughtful questions have other investors asked about this company? The live debates (from sell-side Q&A on the fiscal Q2-2026 call and peer coverage): (1) the PCG compensation-ratio grind — why is operating leverage negative (comp ratio to 65.8%) despite double-digit revenue growth? (mix shift to higher-payout independent advisors + rising recruiting spend); (2) “agentic AI” cash-sweep optimization — does software structurally erode the terminal value of cash-derived profits? (management: cash-sorting already happened without AI; advisor-intermediated platforms have less idle cash to lose); (3) large-M&A probability — with ~$2.1B excess capital and private-equity aggregators struggling to raise, will RJF finally do a needle-moving wealth deal? (4) NII normalization — where does net interest income settle as the Fed eases? (5) advisor-recruiting durability — is the recruiting win-rate a permanent edge or a Commonwealth-disruption one-off?

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Interpretation: mixed — NII/cash-sweep earnings are past their cyclical peak (rates easing, sweep shrunk), while capital-markets/IB earnings are near a cyclical trough (Q2-26 CapMkts pretax only $51M). Net, consolidated earnings are near “mid-cycle,” with the rate tailwind fading and IB optionality to the upside. Driven by external environment or internal actions? Both: markets/rates set the backdrop, but recruiting, retention, SBL growth, and buybacks are internal levers that have driven organic compounding. How stable are revenues? ~55–60% recurring asset-based fees + ~12–15% recurring (rate-sensitive) NII; the cyclical minority is transactional/IB. More stable than a pure investment bank, less than a pure asset manager. Outlook for products/services & market size: U.S. wealth is a large, growing, multi-decade fee pool (aging advisor workforce, wealth transfer, brokerage→advisory mix shift); RJF is a share-gainer. Domestic-dominant (~91%), with small Canada/Europe operations.

Business Quality & Competitive Moat

Is the industry getting more or less competitive? More competitive for advisor talent (escalating transition-assistance/payout war; no platform prices the mobile advisor) but consolidating at the platform level (scale wins). How profitable is the business? ROE 16.7% (FY25), adjusted ROTCE ~21%; pretax margin ~20% — strong and durable, and (critically) earned on a fully-capitalized, positive-tangible-book balance sheet, unlike thin-equity peers. How profitable is the industry / barriers to entry? Oligopolistic, high; barriers are advisor relationships, technology scale, brand/culture, and regulatory/capital requirements. Can it be easily understood? Yes — an advisor-driven wealth platform with a bank and a capital-markets arm. Undermined by foreign low-cost labor? No — advice is local, relationship-based, regulated. Do brands matter? Yes — RJF’s brand/culture is a measurable recruiting and retention advantage (Interpretation, corroborated by win-rate). Nature of competition: for advisors (culture + capabilities + payout + tech) and for client cash (yield). Switching costs: high at the advisor level (repapering, unvested TA, client disruption); the end client largely follows the advisor.

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? The advisor relationships, brand, and recruiting pipeline are intangible economic assets not capitalized. Off-balance-sheet liabilities? Standard for a broker-dealer (client custody, guarantees, litigation contingencies) — nothing unusual flagged; the firm runs conservative. How conservative is the accounting? Conservative — modest non-GAAP adjustments (~$97M pretax, acquisition-related), adequate loan-loss reserves, low-risk loan book (62% SBL+resi mortgage). How CapEx-hungry? Not physically capital-intensive (capex ~$188M FY25) but technology-intensive ($1.1B+ annual tech spend, expensed) — a share-gaining investment rather than maintenance capex. Balance sheet: total assets $88.2B, equity $12.5B, TCE ratio 12.2%, Tier-1 leverage 13.1%, total capital 24.1%, net cash at parent (~$3.0B, ~$1.8B above target), ~$2.1B excess capital. A genuine fortress.

Capital Allocation & Management

How much FCF does the business generate and how is it used? Methodology note: GAAP operating cash flow is not a meaningful FCF proxy for a broker-bank (it swung −$3.5B in FY23 on client-balance flows) — use net income (~$2.1B FY25) as distributable earnings. Uses, in priority: organic reinvestment (recruiting TA, $1.1B+ tech, SBL balance-sheet deployment), then buybacks + a modest dividend. Philosophy: conservative, long-term, owner-oriented — retain capital to compound book value ~13–15%/yr; ~94% of earnings returned TTM. Significant acquisitions recently? TriState Capital (2022, SBL/deposits — a win), GreensLedge (2026, closed), Clark Capital (2026, closing) — bolt-ons; culture-first “keep-it-intact” model. Buying back shares? Yes — ~$1.6B TTM at ~$155 avg; share count 215M→198M over five years; redeemed Series B preferred ($81M). Issuing shares to insiders? Modest SBC (~$254M, ~12% of NI); net repurchaser. Compensation policy: anchored to relative TSR (3-yr) vs. a peer group + performance RSUs — genuinely shareholder-aligned. Motivations of management: long-term stewardship; founder James family retains a meaningful stake; orderly internal CEO succession (Reilly → Shoukry, 2025). Assumption: the culture/long-termism survives the succession — the key soft risk.

Valuation & Market Data

ADR, MLP, or K-1 issuer? No — a U.S. C-corp common stock (NYSE: RJF); standard 1099 dividends. Dividend policy: modest and growing (payout ~19%; yield ~1.3%; quarterly dividend raised to $0.54 in mid-2026) — deliberately low to prioritize reinvestment and buybacks. How profitable? See above (16.7% ROE, ~21% ROTCE, ~20% pretax margin). Is net income diverging from cash from operations? Yes, structurally and harmlessly — GAAP OCF is dominated by client-balance/brokerage-payable swings and is not a quality signal; net income is the correct earnings measure and is high-quality (recurring fees + NII, conservatively reserved).

Risks & Downside

What would cause the stock to decline? Falling rates compressing NII; a market drawdown hitting asset-based fees (spring-2025 saw −28%); persistent NNA deceleration; PCG margin erosion from the advisor-comp war; a prolonged IB drought; the “agentic AI” cash-economics overhang; an ill-timed acquisition. Risk of a catastrophic loss? Very low — fortress capital (24% total capital), net cash, low-risk loan book, diversified recurring revenue; a total loss would require a systemic financial event. Chance of a total loss? Negligible under any non-systemic scenario. The risk profile is earnings-sensitivity/valuation risk, not solvency or fraud risk.

Recent News & Events

Has the business environment changed recently? Yes — the rate cycle turned dovish (a July-2026 Fed-chair signal drove a +9% two-day sector rally in financials including RJF; ironically a mild NII headwind), and cash-sorting has structurally shrunk high-margin sweep balances. Significant acquisitions? GreensLedge (closed Q2-26), Clark Capital (closing) — bolt-ons. Change in accounting policies? None material flagged. Recent changes — new markets, facilities, management? CEO succession (Shoukry, 2025); Series B preferred redemption (Jan-2026); record fee-based AUA and bank loans; an Investor Day (mid-2026) setting longer-term targets; continued heavy AI/technology investment (proprietary advisor “Ray” LLM tool, AI operations agent in pilot).

APPENDIX B — Source Appendix

Research initiation as-of 2026-07-03. Primary sources first. Every non-obvious fact in the memo traces here.

Primary — SEC filings (US filer; CIK 0000720005; FY ends Sep-30)

1. RJF Form 10-K, FY2025 — filed 2025-11-25, for year ended 2025-09-30 (rjf-20250930.htm). Source of: net revenue $13.84B / geographic total net rev $14.07B; net income to common $2,130M; diluted EPS $10.30; PCG AUA $1.67T, fee-based $1.01T, 8,943 advisors; domestic NNA $52.4B (3.8%) / FY24 $60.7B (5.5%) / FY23 $73.3B (7.7%); Tier-1 leverage 13.1%, total capital 24.1%; segment and geographic breakdowns; risk factors (cash-sweep/deposit reliance). SEC EDGAR.
2. RJF Forms 10-K, FY2021–FY2024 (rjf-20210930 … rjf-20240930.htm) — five-year trend data (revenue, EPS, ROE, book value, capital ratios). SEC EDGAR.
3. RJF Forms 10-Q (trailing 5 years, 15 filings) — quarterly segment/AUA/loan/capital detail. SEC EDGAR.
4. RJF DEF 14A proxy statements (2022–2025) — executive compensation (relative-TSR framework, performance RSUs), board/governance, Thomas A. James (Chairman Emeritus, director since 1970) and James-family ownership, beneficial-ownership tables. SEC EDGAR.
5. RJF Forms 8-K (trailing 5 years, ~107) — quarterly earnings releases, capital actions (buyback authorizations, Series B preferred redemption Jan-2026), acquisition announcements (GreensLedge, Clark Capital, TriState), CEO succession. SEC EDGAR.
6. RJF Forms 3/4/5 (trailing 5 years, ~417 Form 4) — insider transactions (index reviewed; no discretionary open-market purchase signal established in this pass — an open question). SEC EDGAR.

Primary — earnings call transcript

7. RJF fiscal Q2-2026 earnings call, 2026-04-22 (via ROIC.ai). CEO Paul Shoukry, CFO Jonathan “Butch” Oorlog. Source of: record net revenue $3.86B (+13% YoY); pretax $735M; adjusted diluted EPS $2.83; ROE 17.3% / adj ROTCE 20.9%; segment detail (PCG rev $2.81B/ptx $416M; CapMkts $464M/$51M; AsstMgmt $327M/$137M; Bank $486M/$166M); bank loans $54.8B (+14%), SBL +31% (=42% of loans); NIM 2.81%; sweep+ESP $57.8B (3.7% of PCG assets); comp ratio 65.8%; non-comp target $2.3B; Tier-1 leverage 12.4% (quarter), total capital 24%, ~$2.1B excess capital; buybacks $400M @ $155, $1.6B TTM, ~94% of earnings returned; Series B pref redemption; M&A/AI commentary. Earlier calls (list_earnings_calls through FY2021) available for trend.

Secondary — quantitative cross-checks (third-party; reconciled to filings)

8. ROIC.ai MCP — income statement, balance sheet, cash flow, profitability/per-share ratios, enterprise value, valuation multiples (FY2020–FY2025). Source of the multi-year trend tables and per-share/book-value/tangible-book figures. Third-party aggregated; reconciled to the 10-K.
9. AZI valuation-index (azi.sh fundamentals RJF → .valuation_index) — own-history percentiles at 2026-07-02: P/E 15.4x (54th pctile), P/S 2.02x (81st), composite 68th; TTM EPS $10.57; TTM sales/sh $80.54. Book-value percentile null (aggregator gap; positive book confirmed via ROIC/10-K).
10. AZI news feed (azi.sh news RJF) — recent-events timeline; the 2026-07-01 Benzinga item (“Shares of banking and financial services companies are trading higher; Fed Chair Warsh…”) establishing the July-1–2 +9% move as a sector rate-rally, not RJF-specific. Multi-name (AFRM, USB, WFC, MET, RJF, etc.).
11. AZI 5-year price history (download-data.php?t=RJF) — split/dividend-adjusted and unadjusted OHLCV; source of the Five-Year Event Map price points (5yr low ~$83 on 2023-05-04; ATH $176.43 on 2025-09-29; 52-wk range ~$138.82–$177.66; $162.66 on 2026-07-02; dividend raised to $0.54 on 2026-07-01).
12. FactorsToday — stock-info (beta 0.94, alpha, RS), stock-loadings (Market ~0.79–0.85, DividendYield ~0.75–0.84; low-vol/quality tilt; R² ~0.61–0.63), leaderboard (10y annualized return ~18%, Sharpe 0.52; y1 +4.2%; m3 strong on the rate rally). Third-party statistical estimates; overlay only.

Secondary — peer / industry cross-reads (public company disclosures)

13. LPL Financial (LPLA) — public filings/earnings — closest independent-broker-dealer peer; cash-sweep NII economics; advisor-recruiting/transition-assistance dynamics; organic-NNA benchmarks; the Commonwealth-integration advisor movement.
14. Ameriprise (AMP) — public filings/earnings — the closest analog (branded, advice-led, bank/NII leg + asset management); cohort valuation and ROE comparison; AWM cash-sweep and fee-vs-NII-offset benchmarks.
15. Charles Schwab (SCHW) — public filings/earnings — cash-sweep economics and the “cash-optimization” debate; NIM/deposit-sorting arc; P/B and ROE comparison; organic-NNA benchmark.
16. Morgan Stanley, Stifel (SF), Goldman Sachs, StoneX (SNEX) — public filings/earnings — cohort multiple, ROE and business-mix comparison; broker-dealer methodology (use ROE not ROIC; read net income not operating cash flow for client-balance-heavy models).

Framework references

17. Competition Demystified (Greenwald & Kahn) — moat taxonomy (customer captivity + local economies of scale) applied in
18. Capital Returns (Marathon) — capital-cycle / industry-consolidation lens applied in /

Note on the July-2026 macro reference: the “Fed Chair Warsh” dovish signal is reported as it appeared in the dated news feed and is used only to attribute the sector price move; it is not independently verified beyond the cited article.